Abstract
BACKGROUND: There is urgency to manage frailty due to its increasing prevalence. The Geriatric Service Hub (GSH) is a novel programme in Singapore, which aims to manage frailty amongst community-dwelling older adults. OBJECTIVES: We aimed to (1) assess the effectiveness of the GSH through patient-outcomes including patient activation, functional status, and quality-of-life (QoL), and (2) assess impact on patient-outcomes through different levels of frailty using the Clinical Frailty Scale (CFS) scores. DESIGN: Single-arm pre-post design. SETTING: Community-based health and social care provider PARTICIPANTS: 218 GSH patients, aged≥65, with CFS4 to CFS7. INTERVENTION: Patients received comprehensive geriatric assessments in community-based settings and had individualised care plans formed by a multi-disciplinary care team. Patients were then referred to health and social services located in the community based on identified needs. MEASUREMENTS: Functional status (Barthel Index), Patient activation (Patient Activation Measure), health-related QoL (EuroQoL 5-dimension 5-level tool) and the emotional-related QoL (Control, Autonomy, Self-realisation, and Pleasure tool). Measurements administered at baseline, 3- and 6-months post-enrolment. Analysis included unadjusted t-tests and multi-level mixed-effects linear regression. RESULTS: We studied 191 (87.6 %) participants who completed all 3-timepoints. Compared to baseline, functional status was maintained at 3-months (M(diff)=-0.2, 95 % CI [-1.8;1.3]) and 6-months (M(diff)=-0.5, 95 % CI[-2.2;1.2]). Patient activation increased slightly at 3-months (M(diff)=3.0, 95 % CI [0.1;5.9]) but not at 6-months (M(diff)=1.5, 95 % CI [-1.2;4.1]). There were significant increases for health-related QoL a t 3-months (M(diff)=0.068, 95 %CI [0.041;0.095]) and 6-months (M(diff)=0.045, 95 % CI [0.016;0.074]), and for emotional-related QoL at 3-months (M(diff)=2.3, 95 % CI [1.2;3.3]) and 6-months (M(diff)=1.5, 95 % CI [0.4;2.7]). For sub-group analyses, there were significant increases for patient activation and both QoL measurements for patients categorised as CFS4 and CFS5, and no significant changes for patient-outcomes for CFS6-7. CONCLUSIONS: Overall, results suggest maintenance in patient activation and functional status, with improvements in QoL. Sub-group analyses suggest that GSH is beneficial for patients categorised as CFS4 and CFS5, but the programme played a largely maintenance role for patients with CFS6-7.